Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin in urinary incontinence.

Jacob M Patterson1, Christopher R Chapple

  • 1Department of Urology, Section of Female Urology, Urodynamics and Reconstructive Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield, UK. jake.patterson@doctors.org.uk

Current Opinion in Urology
|June 14, 2006
PubMed
Summary

Botulinum toxin injections offer a safe and effective treatment for lower urinary tract dysfunction, improving incontinence symptoms. Repeated treatments are also safe and effective, with botulinum toxin A showing a longer duration of action.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025.

Neurourology and urodynamics·2025
Same author

A critical comparison of polypropylene and polyurethane sling materials after implantation in a suburethral sheep model.

Biomaterials·2025
Same author

What Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI-RS 2025.

Neurourology and urodynamics·2025
Same author

From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?

European urology·2025
Same author

Do We Need to Re-Focus on Functional Female Urethral Disorders in Lower Urinary Tract Dysfunction? ICI-RS 2024.

Neurourology and urodynamics·2024
Same author

Development of a Clinically Relevant Preclinical Animal Model to Mimic Suburethral Implantation of Support Materials for Stress Urinary Incontinence.

Neurourology and urodynamics·2024

Area of Science:

  • Urology
  • Pharmacology
  • Nephrology

Background:

  • Lower urinary tract dysfunction (LUTD) affects numerous patients.
  • Current treatments for LUTD, particularly detrusor overactivity, have limitations.
  • Botulinum toxin has emerged as a potential therapeutic agent for LUTD.

Purpose of the Study:

  • To review recent literature on botulinum toxin for treating lower urinary tract dysfunction.
  • To discuss the efficacy, safety, and optimal use of botulinum toxin in managing incontinence.
  • To explore the role of repeated treatments and different botulinum toxin serotypes.

Main Methods:

  • Literature review of published studies on botulinum toxin for LUTD.
  • Analysis of urodynamic and subjective parameters in treated patients.

Related Experiment Videos

  • Evaluation of safety profiles and side effects of botulinum toxin therapy.

    • Main Results:

    • Botulinum toxin demonstrates safety and efficacy in improving urodynamic and subjective parameters for LUTD.
    • Botulinum toxin A offers a longer duration of action and fewer systemic side effects than serotype B.
    • Effective in reducing incontinence associated with detrusor overactivity, with repeated treatments being safe and efficacious across age groups.

    Conclusions:

    • Botulinum toxin is a promising treatment for LUTD, especially for cases refractory to anticholinergics.
    • Further large-scale randomized controlled trials are needed to establish optimal treatment conditions.
    • Ongoing trials are expected to provide more definitive evidence on the long-term efficacy and safety of botulinum toxin for LUTD.